نتایج جستجو برای: persistent pulmonary hypertension of the newborn

تعداد نتایج: 22848984  

Journal: :Paediatrics & child health 2012
Abraham Peliowski

Inhaled nitric oxide (iNO) is a pulmonary vasodilator that plays a major role in regulating vascular muscle tone. It has emerged as a treatment for hypoxemic respiratory failure in newly born infants that is associated with persistent high pulmonary vascular pressure and resultant right-to-left shunting of blood (persistent pulmonary hypertension of the newborn). Current evidence shows that iNO...

Journal: :Journal of the American College of Cardiology 2009
Gerald Simonneau Michael A Gatzoulis Ian Adatia David Celermajer Chris Denton Ardeschir Ghofrani Miguel Angel Gomez Sanchez R Krishna Kumar Michael Landzberg Roberto F Machado Horst Olschewski Ivan M Robbins Rogiero Souza

In 1998, a clinical classification of pulmonary hypertension (PH) was established, categorizing PH into groups which share similar pathological and hemodynamic characteristics and therapeutic approaches. During the 5th World Symposium held in Nice, France, in 2013, the consensus was reached to maintain the general scheme of previous clinical classifications. However, modifications and updates e...

2016
Mona Hanouni Gilberto Bernal Shaemion McBride Vincent Reginald F. Narvaez Basil O. Ibe

Platelet-activating factor (PAF) acting via its receptor (PAFR) is implicated in the pathogenesis of persistent pulmonary hypertension of the newborn (PPHN). Effects of long-term oxygen therapy on newborn lung are not well understood; therefore, we studied the effect of oxygen tension on ovine newborn pulmonary artery smooth muscle cells (NBPASMC). Our global hypothesis is that PPHN results fro...

Journal: :Expert review of respiratory medicine 2014
Willemijn M H Zijlstra Mark-Jan Ploegstra Rolf M F Berger

Pulmonary arterial hypertension (PAH) is a severe and progressive intrinsic disease of the precapillary lung vasculature. Since the introduction of PAH-targeted drugs, survival of PAH patients seems to have improved. Randomized controlled trials have led to evidence-based guidelines to direct treatment in adults. However, since disease characteristics differ between adults and children, it is h...

Journal: :American journal of physiology. Lung cellular and molecular physiology 2014
Masahiro Enomoto Amish Jain Jingyi Pan Yulia Shifrin Todd Van Vliet Patrick J McNamara Robert P Jankov Jaques Belik

Inhaled nitric oxide (NO) and other cGMP- or cAMP-dependent pulmonary vasodilators are often used in combination for the treatment of the persistent pulmonary hypertension of the newborn syndrome. There is in vitro evidence to indicate that NO downregulate the pulmonary vascular response to cGMP-dependent agonists raising concern as to whether a synergistic effect is observed when employing a c...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید